Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
eli lilly
life sciences
migraine
5
×
national blog main
clinical trials
fda
indiana blog main
indiana top stories
national
national top stories
new york blog main
teva pharmaceutical
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan
biohaven
calcitonin gene-related peptide
cancer
cancer immunotherapy
crispr
What
new
5
×
approval
class
drug
fda
migraine
approved
bio
companies
drugs
medicines
roundup
won
adults
allergan
announced
arguments
bails
big
biogen’s
biopharmaceutical
brand
bridgebio
capital
car
commercialized
competitors
convo
decades
decision
develop
developed
earlier
eli
emerges
failures
firm
grab
headache
headlines
Language
unset
Current search:
migraine
×
new
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
